121 related articles for article (PubMed ID: 38308252)
1. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
Akalu TY; Clements ACA; Gebreyohannes EA; Xu Z; Bai L; Alene KA
BMC Infect Dis; 2024 Feb; 24(1):159. PubMed ID: 38308252
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
[TBL] [Abstract][Full Text] [Related]
3. Determinants of drug-resistant tuberculosis in Hunan province, China: a case-control study.
Akalu TY; Clements ACA; Xu Z; Bai L; Alene KA
BMC Infect Dis; 2024 Feb; 24(1):198. PubMed ID: 38350860
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis.
Koroma JA; Elduma AH; Sesay U; Gebru GN
BMC Infect Dis; 2024 Jun; 24(1):579. PubMed ID: 38862873
[TBL] [Abstract][Full Text] [Related]
5. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study.
Hirpa S; Medhin G; Girma B; Melese M; Mekonen A; Suarez P; Ameni G
BMC Public Health; 2013 Aug; 13():782. PubMed ID: 23981845
[TBL] [Abstract][Full Text] [Related]
6. Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study.
Chen B; Chen X; Ren Y; Peng Y; Wang F; Zhou L; Xu B
J Infect Public Health; 2023 Jul; 16(7):1073-1080. PubMed ID: 37209611
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia.
Erkihun M; Kiros T; Berhan A; Ayele B
J Med Microbiol; 2023 Dec; 72(12):. PubMed ID: 38099651
[No Abstract] [Full Text] [Related]
8. Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study.
Li M; Zhang Y; Wu Z; Jiang Y; Sun R; Yang J; Li J; Lin H; Zhang R; Jiang Q; Wang L; Wu X; Yu F; Yuan J; Yang C; Shen X
Emerg Microbes Infect; 2024 Dec; 13(1):2302837. PubMed ID: 38205528
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study.
Panford V; Kumah E; Kokuro C; Adoma PO; Baidoo MA; Fusheini A; Ankomah SE; Agyei SK; Agyei-Baffour P
BMJ Open; 2022 Jul; 12(7):e062857. PubMed ID: 35790328
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.
Peng Y; Chen SH; Zhang L; Chen B; Zhang MW; He TN; Wang F; Chai CL; Zhou L; Zhang Y; Wang XM; Jia Z
Chin Med J (Engl); 2017 Sep; 130(17):2021-2026. PubMed ID: 28836544
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study.
Admassu F; Abera E; Gizachew A; Sedoro T; Gari T
BMJ Open; 2023 Jan; 13(1):e061836. PubMed ID: 36639214
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Non-Adherence for Prescribed Treatment in 201 Patients with Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in Anhui Province, China.
Zhu QQ; Wang J; Sam NB; Luo J; Liu J; Pan HF
Med Sci Monit; 2022 Apr; 28():e935334. PubMed ID: 35437301
[TBL] [Abstract][Full Text] [Related]
13. Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia.
Bykov I; Dyachenko O; Ratmanov P; Liu H; Liang L; Wu Q
BMC Infect Dis; 2022 Jul; 22(1):612. PubMed ID: 35831812
[TBL] [Abstract][Full Text] [Related]
14. Pediatric multi-drug-resistant tuberculosis in Germany - diagnostic and therapeutic challenges of an "orphan disease".
Schäfer HL; Barker M; Follmann P; Günther A; Hörning A; Kaiser-Labusch P; Kerzel S; Maier C; Roth S; Schmidt C; Schütz K; Stehling F; Struffert M; Timmesfeld N; Vöhringer P; Brinkmann F
Eur J Pediatr; 2023 Nov; 182(11):5167-5179. PubMed ID: 37707590
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for mortality among multi-drug resistant tuberculosis patients in treatment follow-up centers, eastern Ethiopia: a retrospective follow-up study.
Bofe KU
Pan Afr Med J; 2022; 43():78. PubMed ID: 36591001
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China.
Wang Z; Hou Y; Guo T; Jiang T; Xu L; Hu H; Zhao Z; Xue Y
Front Public Health; 2023; 11():1117101. PubMed ID: 37228738
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and transmission of pyrazinamide-resistant
Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
[No Abstract] [Full Text] [Related]
18. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study.
Li Q; Lu M; Hsieh E; Wu L; Wu Y; Wang M; Wang L; Zhao G; Xie L; Qian HZ
Medicine (Baltimore); 2020 Dec; 99(50):e23649. PubMed ID: 33327347
[TBL] [Abstract][Full Text] [Related]
19. Successful Multidrug-Resistant Tuberculosis Treatment Without HIV Viral Suppression: A Missed Opportunity.
Geiger K; Patil A; Budhathoki C; Dooley KE; Lowensen K; Ndjeka N; Ngozo J; Farley JE
J Acquir Immune Defic Syndr; 2023 Nov; 94(3):253-261. PubMed ID: 37757847
[TBL] [Abstract][Full Text] [Related]
20. Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
Song WM; Li SJ; Liu JY; Fu Q; Xu TT; Tao NN; Zhang QY; Liu SQ; An QQ; Zhu XH; Liu Y; Yu CB; Li YF; Dong J; Li HC
BMJ Open; 2022 Jul; 12(7):e059149. PubMed ID: 35902191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
